_id
6915fdc3bc934aba376b2821
Ticker
SPRY
Name
ARS Pharmaceuticals, Inc
Exchange
NASDAQ
Address
11682 El Camino Real, San Diego, CA, United States, 92130
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://ars-pharma.com
Description
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.
Last Close
11.22
Volume
1586932
Current Price
10.24
Change
-8.734402852049914
Last Updated
2025-12-04T13:27:39.970Z
Image
data:image/webp;base64,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
Ipo Date
2020-12-04T00:00:00.000Z
Market Cap
944004224
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9642461538461539
Sentiment Sources
13
Rating
4.8333
Target Price
28.6667
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
32501000
Cost Of Revenue
8191000
Gross Profit
24310000
Operating Expenses
77502000
Operating Income
-53192000
Interest Expense
-
Pretax Income
-51151000
Net Income
-51151000
Eps
-0.5176828503070614
Dividends Per Share
-
Shares Outstanding
98848611
Income Tax Expense
-
EBITDA
-48799000
Operating Margin
-163.6626565336451
Total Other Income Expense Net
2041000
Cash
59557000
Short Term Investments
228652000
Receivables
36451000
Inventories
7782000
Total Current Assets
338863000
Property Plant Equipment
2648000
Total Assets
372803000
Payables
8382000
Short Term Debt
583000
Long Term Debt
96229000
Total Liabilities
225148000
Equity
147655000
Depreciation
2352000
Change In Working Capital
-1070000
Cash From Operations
-47047000
Capital Expenditures
197000
Cash From Investing
-44981000
Cash From Financing
100045000
Net Change In Cash
8017000
PE
-
PB
6.85239120923775
ROE
-34.64224035759033
ROA
-13.720651389607916
FCF
-47244000
Fcf Percent
-1.4536168117904065
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
1.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
6.5
Net Net Investing Score
1
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
32501000
Quarters > 0 > income Statement > cost Of Revenue
8191000
Quarters > 0 > income Statement > gross Profit
24310000
Quarters > 0 > income Statement > operating Expenses
77502000
Quarters > 0 > income Statement > operating Income
-53192000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-51151000
Quarters > 0 > income Statement > net Income
-51151000
Quarters > 0 > income Statement > eps
-0.5176828503070614
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
98807600
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-48799000
Quarters > 0 > income Statement > operating Margin
-163.6626565336451
Quarters > 0 > income Statement > total Other Income Expense Net
2041000
Quarters > 0 > balance Sheet > cash
59557000
Quarters > 0 > balance Sheet > short Term Investments
228652000
Quarters > 0 > balance Sheet > receivables
36451000
Quarters > 0 > balance Sheet > inventories
7782000
Quarters > 0 > balance Sheet > total Current Assets
338863000
Quarters > 0 > balance Sheet > property Plant Equipment
2648000
Quarters > 0 > balance Sheet > total Assets
372803000
Quarters > 0 > balance Sheet > payables
8382000
Quarters > 0 > balance Sheet > short Term Debt
583000
Quarters > 0 > balance Sheet > long Term Debt
96229000
Quarters > 0 > balance Sheet > total Liabilities
225148000
Quarters > 0 > balance Sheet > equity
147655000
Quarters > 0 > cash Flow > net Income
-51151000
Quarters > 0 > cash Flow > depreciation
2352000
Quarters > 0 > cash Flow > change In Working Capital
-1070000
Quarters > 0 > cash Flow > cash From Operations
-47047000
Quarters > 0 > cash Flow > capital Expenditures
197000
Quarters > 0 > cash Flow > cash From Investing
-44981000
Quarters > 0 > cash Flow > cash From Financing
100045000
Quarters > 0 > cash Flow > net Change In Cash
8017000
Quarters > 0 > ratios > PE
-0.5176828503070614
Quarters > 0 > ratios > PB
6.85239120923775
Quarters > 0 > ratios > ROE
-34.64224035759033
Quarters > 0 > ratios > ROA
-13.720651389607916
Quarters > 0 > ratios > FCF
-47244000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.4536168117904065
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
15717000
Quarters > 1 > income Statement > cost Of Revenue
4984000
Quarters > 1 > income Statement > gross Profit
10733000
Quarters > 1 > income Statement > operating Expenses
58347000
Quarters > 1 > income Statement > operating Income
-47614000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-44883000
Quarters > 1 > income Statement > net Income
-44883000
Quarters > 1 > income Statement > eps
-0.4563053261820591
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
98361771
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-44604000
Quarters > 1 > income Statement > operating Margin
-302.945854806897
Quarters > 1 > income Statement > total Other Income Expense Net
2731000
Quarters > 1 > balance Sheet > cash
51540000
Quarters > 1 > balance Sheet > short Term Investments
188590000
Quarters > 1 > balance Sheet > receivables
26082000
Quarters > 1 > balance Sheet > inventories
8738000
Quarters > 1 > balance Sheet > total Current Assets
281436000
Quarters > 1 > balance Sheet > property Plant Equipment
2639000
Quarters > 1 > balance Sheet > total Assets
313472000
Quarters > 1 > balance Sheet > payables
15559000
Quarters > 1 > balance Sheet > short Term Debt
589000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
121151000
Quarters > 1 > balance Sheet > equity
192321000
Quarters > 1 > cash Flow > net Income
-44883000
Quarters > 1 > cash Flow > depreciation
279000
Quarters > 1 > cash Flow > change In Working Capital
-1052000
Quarters > 1 > cash Flow > cash From Operations
-39592000
Quarters > 1 > cash Flow > capital Expenditures
51000
Quarters > 1 > cash Flow > cash From Investing
48571000
Quarters > 1 > cash Flow > cash From Financing
2697000
Quarters > 1 > cash Flow > net Change In Cash
11676000
Quarters > 1 > ratios > PE
-0.4563053261820591
Quarters > 1 > ratios > PB
5.2372051676104014
Quarters > 1 > ratios > ROE
-23.3375450418831
Quarters > 1 > ratios > ROA
-14.318025214373215
Quarters > 1 > ratios > FCF
-39643000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-2.5223006935165744
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
7973000
Quarters > 2 > income Statement > cost Of Revenue
4046000
Quarters > 2 > income Statement > gross Profit
3927000
Quarters > 2 > income Statement > operating Expenses
41104000
Quarters > 2 > income Statement > operating Income
-37177000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-33940000
Quarters > 2 > income Statement > net Income
-33940000
Quarters > 2 > income Statement > eps
-0.34611237887545415
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
98060636
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-36897000
Quarters > 2 > income Statement > operating Margin
-466.2862159789289
Quarters > 2 > income Statement > total Other Income Expense Net
3237000
Quarters > 2 > balance Sheet > cash
39864000
Quarters > 2 > balance Sheet > short Term Investments
235863000
Quarters > 2 > balance Sheet > receivables
10274000
Quarters > 2 > balance Sheet > inventories
7270000
Quarters > 2 > balance Sheet > total Current Assets
303860000
Quarters > 2 > balance Sheet > property Plant Equipment
1147000
Quarters > 2 > balance Sheet > total Assets
327318000
Quarters > 2 > balance Sheet > payables
4095000
Quarters > 2 > balance Sheet > short Term Debt
73000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
98344000
Quarters > 2 > balance Sheet > equity
228974000
Quarters > 2 > cash Flow > net Income
-33940000
Quarters > 2 > cash Flow > depreciation
-1681000
Quarters > 2 > cash Flow > change In Working Capital
-10419000
Quarters > 2 > cash Flow > cash From Operations
-40742000
Quarters > 2 > cash Flow > capital Expenditures
91000
Quarters > 2 > cash Flow > cash From Investing
29064000
Quarters > 2 > cash Flow > cash From Financing
725000
Quarters > 2 > cash Flow > net Change In Cash
-10953000
Quarters > 2 > ratios > PE
-0.34611237887545415
Quarters > 2 > ratios > PB
4.385392719872125
Quarters > 2 > ratios > ROE
-14.822643618926165
Quarters > 2 > ratios > ROA
-10.369121160461692
Quarters > 2 > ratios > FCF
-40833000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-5.121409757933024
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
86581000
Quarters > 3 > income Statement > cost Of Revenue
3892000
Quarters > 3 > income Statement > gross Profit
82689000
Quarters > 3 > income Statement > operating Expenses
35492000
Quarters > 3 > income Statement > operating Income
47197000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
50222000
Quarters > 3 > income Statement > net Income
49934000
Quarters > 3 > income Statement > eps
0.5097689968733542
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
97954172
Quarters > 3 > income Statement > income Tax Expense
288000
Quarters > 3 > income Statement > EBITDA
47226000
Quarters > 3 > income Statement > operating Margin
54.51195989882307
Quarters > 3 > income Statement > total Other Income Expense Net
3025000
Quarters > 3 > balance Sheet > cash
50817000
Quarters > 3 > balance Sheet > short Term Investments
263205000
Quarters > 3 > balance Sheet > receivables
9162000
Quarters > 3 > balance Sheet > inventories
5212000
Quarters > 3 > balance Sheet > total Current Assets
334295000
Quarters > 3 > balance Sheet > property Plant Equipment
1066000
Quarters > 3 > balance Sheet > total Assets
351153000
Quarters > 3 > balance Sheet > payables
9870000
Quarters > 3 > balance Sheet > short Term Debt
42000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
94355000
Quarters > 3 > balance Sheet > equity
256798000
Quarters > 3 > cash Flow > net Income
49934000
Quarters > 3 > cash Flow > depreciation
-1515000
Quarters > 3 > cash Flow > change In Working Capital
-10678000
Quarters > 3 > cash Flow > cash From Operations
42004000
Quarters > 3 > cash Flow > capital Expenditures
302000
Quarters > 3 > cash Flow > cash From Investing
-101760000
Quarters > 3 > cash Flow > cash From Financing
70916000
Quarters > 3 > cash Flow > net Change In Cash
11160000
Quarters > 3 > ratios > PE
0.5097689968733542
Quarters > 3 > ratios > PB
3.9059911731399777
Quarters > 3 > ratios > ROE
19.444855489528734
Quarters > 3 > ratios > ROA
14.220012359284983
Quarters > 3 > ratios > FCF
41702000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.4816530185606542
Quarters > 3 > health Score
88
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
89149000
Annuals > 0 > income Statement > cost Of Revenue
20557000
Annuals > 0 > income Statement > gross Profit
68592000
Annuals > 0 > income Statement > operating Expenses
71675000
Annuals > 0 > income Statement > operating Income
-3083000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
8286000
Annuals > 0 > income Statement > net Income
7998000
Annuals > 0 > income Statement > eps
0.07811246530792777
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
102390828
Annuals > 0 > income Statement > income Tax Expense
288000
Annuals > 0 > income Statement > EBITDA
-3004000
Annuals > 0 > income Statement > operating Margin
-3.4582552804854796
Annuals > 0 > income Statement > total Other Income Expense Net
11369000
Annuals > 0 > balance Sheet > cash
50817000
Annuals > 0 > balance Sheet > short Term Investments
263205000
Annuals > 0 > balance Sheet > receivables
9162000
Annuals > 0 > balance Sheet > inventories
5212000
Annuals > 0 > balance Sheet > total Current Assets
334295000
Annuals > 0 > balance Sheet > property Plant Equipment
1066000
Annuals > 0 > balance Sheet > total Assets
351153000
Annuals > 0 > balance Sheet > payables
9870000
Annuals > 0 > balance Sheet > short Term Debt
42000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
94355000
Annuals > 0 > balance Sheet > equity
256798000
Annuals > 0 > cash Flow > net Income
7998000
Annuals > 0 > cash Flow > depreciation
-7175000
Annuals > 0 > cash Flow > change In Working Capital
-1809000
Annuals > 0 > cash Flow > cash From Operations
13548000
Annuals > 0 > cash Flow > capital Expenditures
563000
Annuals > 0 > cash Flow > cash From Investing
-106101000
Annuals > 0 > cash Flow > cash From Financing
72399000
Annuals > 0 > cash Flow > net Change In Cash
-20154000
Annuals > 0 > ratios > PE
0.07811246530792777
Annuals > 0 > ratios > PB
3.8077882514661336
Annuals > 0 > ratios > ROE
3.1145102376186733
Annuals > 0 > ratios > ROA
2.2776396613442005
Annuals > 0 > ratios > FCF
12985000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.14565502697730764
Annuals > 0 > health Score
63
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
30000
Annuals > 1 > income Statement > cost Of Revenue
73000
Annuals > 1 > income Statement > gross Profit
30000
Annuals > 1 > income Statement > operating Expenses
67550000
Annuals > 1 > income Statement > operating Income
-67520000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-54365000
Annuals > 1 > income Statement > net Income
-54365000
Annuals > 1 > income Statement > eps
-0.5709690295433754
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
95215322
Annuals > 1 > income Statement > income Tax Expense
-94895
Annuals > 1 > income Statement > EBITDA
-67447000
Annuals > 1 > income Statement > operating Margin
-225066.66666666666
Annuals > 1 > income Statement > total Other Income Expense Net
13155000
Annuals > 1 > balance Sheet > cash
70971000
Annuals > 1 > balance Sheet > short Term Investments
157389000
Annuals > 1 > balance Sheet > receivables
795000
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
231563000
Annuals > 1 > balance Sheet > property Plant Equipment
824000
Annuals > 1 > balance Sheet > total Assets
233188000
Annuals > 1 > balance Sheet > payables
759000
Annuals > 1 > balance Sheet > short Term Debt
237000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2428000
Annuals > 1 > balance Sheet > equity
230760000
Annuals > 1 > cash Flow > net Income
-54365000
Annuals > 1 > cash Flow > depreciation
73000
Annuals > 1 > cash Flow > change In Working Capital
-7331000
Annuals > 1 > cash Flow > cash From Operations
-59266000
Annuals > 1 > cash Flow > capital Expenditures
175000
Annuals > 1 > cash Flow > cash From Investing
-87180000
Annuals > 1 > cash Flow > cash From Financing
6899000
Annuals > 1 > cash Flow > net Change In Cash
-139547000
Annuals > 1 > ratios > PE
-0.5709690295433754
Annuals > 1 > ratios > PB
3.940485028167794
Annuals > 1 > ratios > ROE
-23.55910903102791
Annuals > 1 > ratios > ROA
-23.313806885431497
Annuals > 1 > ratios > FCF
-59441000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-1981.3666666666666
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1316000
Annuals > 2 > income Statement > cost Of Revenue
319000
Annuals > 2 > income Statement > gross Profit
1316000
Annuals > 2 > income Statement > operating Expenses
36832000
Annuals > 2 > income Statement > operating Income
-35516000
Annuals > 2 > income Statement > interest Expense
834000
Annuals > 2 > income Statement > pretax Income
-34682000
Annuals > 2 > income Statement > net Income
-34682000
Annuals > 2 > income Statement > eps
-0.868003871154108
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
39956043
Annuals > 2 > income Statement > income Tax Expense
-694000
Annuals > 2 > income Statement > EBITDA
-35197000
Annuals > 2 > income Statement > operating Margin
-2698.7841945288756
Annuals > 2 > income Statement > total Other Income Expense Net
834000
Annuals > 2 > balance Sheet > cash
210518000
Annuals > 2 > balance Sheet > short Term Investments
63863000
Annuals > 2 > balance Sheet > receivables
1009000
Annuals > 2 > balance Sheet > inventories
-1009000
Annuals > 2 > balance Sheet > total Current Assets
277700000
Annuals > 2 > balance Sheet > property Plant Equipment
774000
Annuals > 2 > balance Sheet > total Assets
281435000
Annuals > 2 > balance Sheet > payables
1659000
Annuals > 2 > balance Sheet > short Term Debt
230000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
8549000
Annuals > 2 > balance Sheet > equity
272886000
Annuals > 2 > cash Flow > net Income
-34682000
Annuals > 2 > cash Flow > depreciation
319000
Annuals > 2 > cash Flow > change In Working Capital
-12754000
Annuals > 2 > cash Flow > cash From Operations
-40078000
Annuals > 2 > cash Flow > capital Expenditures
199000
Annuals > 2 > cash Flow > cash From Investing
-199000
Annuals > 2 > cash Flow > cash From Financing
190732000
Annuals > 2 > cash Flow > net Change In Cash
150455000
Annuals > 2 > ratios > PE
-0.868003871154108
Annuals > 2 > ratios > PB
1.3983136205228557
Annuals > 2 > ratios > ROE
-12.70933649949063
Annuals > 2 > ratios > ROA
-12.323271803435961
Annuals > 2 > ratios > FCF
-40277000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-30.60562310030395
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
5506000
Annuals > 3 > income Statement > cost Of Revenue
213000
Annuals > 3 > income Statement > gross Profit
5293000
Annuals > 3 > income Statement > operating Expenses
24747000
Annuals > 3 > income Statement > operating Income
-19454000
Annuals > 3 > income Statement > interest Expense
106000
Annuals > 3 > income Statement > pretax Income
-20243000
Annuals > 3 > income Statement > net Income
-20243000
Annuals > 3 > income Statement > eps
-0.7011232449492492
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
28872242
Annuals > 3 > income Statement > income Tax Expense
-230558
Annuals > 3 > income Statement > EBITDA
-19241000
Annuals > 3 > income Statement > operating Margin
-353.3236469306211
Annuals > 3 > income Statement > total Other Income Expense Net
-789000
Annuals > 3 > balance Sheet > cash
60063000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
1000
Annuals > 3 > balance Sheet > inventories
-6781000
Annuals > 3 > balance Sheet > total Current Assets
60730000
Annuals > 3 > balance Sheet > property Plant Equipment
693000
Annuals > 3 > balance Sheet > total Assets
61446000
Annuals > 3 > balance Sheet > payables
1786000
Annuals > 3 > balance Sheet > short Term Debt
3623000
Annuals > 3 > balance Sheet > long Term Debt
4930000
Annuals > 3 > balance Sheet > total Liabilities
92715000
Annuals > 3 > balance Sheet > equity
-31269000
Annuals > 3 > cash Flow > net Income
-20243000
Annuals > 3 > cash Flow > depreciation
213000
Annuals > 3 > cash Flow > change In Working Capital
-356000
Annuals > 3 > cash Flow > cash From Operations
-17561000
Annuals > 3 > cash Flow > capital Expenditures
55000
Annuals > 3 > cash Flow > cash From Investing
-55000
Annuals > 3 > cash Flow > cash From Financing
53158000
Annuals > 3 > cash Flow > net Change In Cash
35542000
Annuals > 3 > ratios > PE
-0.7011232449492492
Annuals > 3 > ratios > PB
-8.817995813745243
Annuals > 3 > ratios > ROE
64.73823915059643
Annuals > 3 > ratios > ROA
-32.94437392181753
Annuals > 3 > ratios > FCF
-17616000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-3.1994188158372685
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.5176828503070614
Valuation > metrics > PB
6.85239120923775
Valuation > final Score
20
Valuation > verdict
128.4% Overvalued
Profitability > metrics > ROE
-34.64224035759033
Profitability > metrics > ROA
-15.09489085559651
Profitability > metrics > Net Margin
-1.5738284975846897
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.5248247604212521
Risk > metrics > Interest Coverage
-22.6156462585034
Risk > final Score
-60
Risk > verdict
High
Liquidity > metrics > Current Ratio
37.798438371444504
Liquidity > metrics > Quick Ratio
36.930395984383715
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
27.627948323895986
Prev Valuations > 1
36.14607280127875
Prev Valuations > 2
60.94008826860022
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
99
Prev Risks > 0
-635
Prev Risks > 1
10
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:25:06.747Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.52
Earnings History > 0 > eps Estimate
-0.4581
Earnings History > 0 > eps Difference
-0.0619
Earnings History > 0 > surprise Percent
-13.5123
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.46
Earnings History > 1 > eps Estimate
-0.46
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
0
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.35
Earnings History > 2 > eps Estimate
-0.11
Earnings History > 2 > eps Difference
-0.24
Earnings History > 2 > surprise Percent
-218.1818
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-19
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0.51
Earnings History > 3 > eps Estimate
-0.1175
Earnings History > 3 > eps Difference
0.6275
Earnings History > 3 > surprise Percent
534.0426
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.2
Earnings History > 4 > eps Estimate
-0.15
Earnings History > 4 > eps Difference
-0.05
Earnings History > 4 > surprise Percent
-33.3333
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-06
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.13
Earnings History > 5 > eps Estimate
-0.12
Earnings History > 5 > eps Difference
-0.01
Earnings History > 5 > surprise Percent
-8.3333
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.11
Earnings History > 6 > eps Estimate
-0.11
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
0
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-21
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.07
Earnings History > 7 > eps Estimate
-0.14
Earnings History > 7 > eps Difference
0.07
Earnings History > 7 > surprise Percent
50
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.16
Earnings History > 8 > eps Estimate
-0.18
Earnings History > 8 > eps Difference
0.02
Earnings History > 8 > surprise Percent
11.1111
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.18
Earnings History > 9 > eps Estimate
-0.17
Earnings History > 9 > eps Difference
-0.01
Earnings History > 9 > surprise Percent
-5.8824
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.16
Earnings History > 10 > eps Estimate
-0.17
Earnings History > 10 > eps Difference
0.01
Earnings History > 10 > surprise Percent
5.8824
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.77
Earnings History > 11 > eps Estimate
-0.13
Earnings History > 11 > eps Difference
0.9
Earnings History > 11 > surprise Percent
692.3077
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-02
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.5
Earnings History > 12 > eps Estimate
-0.35
Earnings History > 12 > eps Difference
-0.15
Earnings History > 12 > surprise Percent
-42.8571
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.55
Earnings History > 13 > eps Estimate
-0.48
Earnings History > 13 > eps Difference
-0.07
Earnings History > 13 > surprise Percent
-14.5833
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.7
Earnings History > 14 > eps Estimate
-0.54
Earnings History > 14 > eps Difference
-0.16
Earnings History > 14 > surprise Percent
-29.6296
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.67
Earnings History > 15 > eps Estimate
-0.7
Earnings History > 15 > eps Difference
0.03
Earnings History > 15 > surprise Percent
4.2857
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.65
Earnings History > 16 > eps Estimate
-0.67
Earnings History > 16 > eps Difference
0.02
Earnings History > 16 > surprise Percent
2.9851
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.7
Earnings History > 17 > eps Estimate
-0.53
Earnings History > 17 > eps Difference
-0.17
Earnings History > 17 > surprise Percent
-32.0755
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.54
Earnings History > 18 > eps Estimate
-0.35
Earnings History > 18 > eps Difference
-0.19
Earnings History > 18 > surprise Percent
-54.2857
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-29
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-1.37
Earnings History > 19 > eps Estimate
-0.49
Earnings History > 19 > eps Difference
-0.88
Earnings History > 19 > surprise Percent
-179.5918
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-10
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.7
Earnings History > 20 > eps Estimate
-1.1
Earnings History > 20 > eps Difference
0.4
Earnings History > 20 > surprise Percent
36.3636
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AInstitution Moves: How geopolitical tensions affect SPRY stock - Weekly Stock Summary & Fast Moving Stock Watchlists moha.gov.vn
Read more →Discipline and Rules-Based Execution in SPRY Response news.stocktradersdaily.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$28.6667
Analyst Picks
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 80.94% of the total shares of ARS Pharmaceuticals, Inc
1.
RA Capital Management, LLC(10.99%)
since
2025/06/30
2.
Deerfield Management Co(9.84%)
since
2025/06/30
3.
Orbimed Advisors, LLC(8.3869%)
since
2025/06/30
4.
BlackRock Inc(4.476%)
since
2025/06/30
5.
SR ONE CAPITAL MANAGEMENT, LP(4.0606%)
since
2025/06/30
6.
AllianceBernstein L.P.(3.8712%)
since
2025/06/30
7.
Vanguard Group Inc(3.3014%)
since
2025/06/30
8.
Citadel Advisors Llc(2.2688%)
since
2025/06/30
9.
State Street Corp(2.2206%)
since
2025/06/30
10.
Franklin Resources Inc(1.8505%)
since
2025/06/30
11.
Vanguard Total Stock Mkt Idx Inv(1.7758%)
since
2025/07/31
12.
Adage Capital Partners Gp LLC(1.7485%)
since
2025/06/30
13.
Southpoint Capital Advisors LP(1.7294%)
since
2025/06/30
14.
FMR Inc(1.5856%)
since
2025/06/30
15.
Aberdeen Group PLC(1.5204%)
since
2025/06/30
16.
Goldman Sachs Group Inc(1.4817%)
since
2025/06/30
17.
Wellington Management Company LLP(1.4502%)
since
2025/06/30
18.
Octagon Capital Advisors LP(1.366%)
since
2025/06/30
19.
Geode Capital Management, LLC(1.3583%)
since
2025/06/30
20.
iShares Russell 2000 ETF(1.3429%)
since
2025/08/31
21.
MPM Oncology Impact Management LP(1.3189%)
since
2025/06/30
22.
Rubric Capital Management LP(1.3103%)
since
2025/06/30
23.
AB Small Cap Growth A(1.062%)
since
2025/07/31
24.
Franklin Biotechnology Discv A(acc)USD(1.0595%)
since
2025/08/31
25.
SPDR® S&P Biotech ETF(0.9967%)
since
2025/08/31
26.
abrdn Healthcare Investors(0.9845%)
since
2025/08/31
27.
Fidelity Select Biotechnology(0.9135%)
since
2025/07/31
28.
MEDICAL BioHealth EUR Acc(0.8239%)
since
2025/06/30
29.
AB Discovery Growth A(0.7501%)
since
2025/07/31
30.
abrdn Healthcare Opportunities(0.6783%)
since
2025/07/31
31.
Vanguard Institutional Extnd Mkt Idx Tr(0.5761%)
since
2025/07/31
32.
Franklin Biotechnology Discovery A(0.5682%)
since
2025/07/31
33.
Fidelity Small Cap Index(0.5571%)
since
2025/06/30
34.
APO Medical Opportunities R(0.509%)
since
2025/07/31
35.
iShares Russell 2000 Growth ETF(0.4903%)
since
2025/08/31
36.
Heptagon Driehaus US Micro Cap Eq C$ Acc(0.41%)
since
2025/07/31
37.
abrdn Life Sciences Investors(0.3804%)
since
2025/08/31
38.
iShares Biotechnology ETF(0.3317%)
since
2025/08/31
39.
EQ/AB Small Cap Growth IB(0.3024%)
since
2025/07/31
40.
Lisanti Small Cap Growth Composite(0.2949%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.52
EPS Estimate
-0.4581
EPS Difference
-0.0619
Surprise Percent
-13.5123%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.